ICAD INC. - COMMON STO

iCAD Announces Estimated Q1 Revenues and Upcoming CFO Transition

05 Apr 2021 16:01:00 By Nasdaq GlobeNewswire

New Research Indicates ProFound AI May Reduce Interval Breast Cancer Rates

31 Mar 2021 08:00:01 By Nasdaq GlobeNewswire

iCAD Announces FDA Clearance for ProFound AI Version 3.0 for 3D Mammography

15 Mar 2021 18:04:42 By Nasdaq GlobeNewswire

New Research Supporting ProFound AI Presented at European Congress of Radiology Online Meeting

08 Mar 2021 12:36:23 By Nasdaq GlobeNewswire

iCAD to Participate in the Cowen 41st Annual Health Care Conference

03 Mar 2021 21:16:22 By Nasdaq GlobeNewswire

iCAD Announces Pricing of $22.0 Million Public Offering of Common Stock

03 Mar 2021 00:47:48 By Nasdaq GlobeNewswire

iCAD Announces Proposed Public Offering of Common Stock

02 Mar 2021 16:01:00 By Nasdaq GlobeNewswire

iCAD Reports Financial Results for Fourth Quarter and Year Ended December 31, 2020

24 Feb 2021 16:01:01 By Nasdaq GlobeNewswire

iCAD to Report Fourth Quarter 2020 Financial Results on Wednesday, February 24

18 Feb 2021 18:56:26 By Nasdaq GlobeNewswire

iCAD to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

16 Feb 2021 16:01:00 By Nasdaq GlobeNewswire

iCAD to Participate in B. Riley Securities Virtual Oncology Investor Conference

19 Jan 2021 08:00:02 By Nasdaq GlobeNewswire

iCAD to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event

06 Jan 2021 16:01:00 By Nasdaq GlobeNewswire